2021 ESVS临床实践指南:静脉血栓形成的管理

2020-12-09 欧洲血管外科学会 Eur J Vasc Endovasc Surg . 2020 Dec 9;

2020年12月,欧洲血管外科学会(ESVS)发布了静脉血栓形成的管理指南,指南的主要目的是帮助临床医生选择最佳管理策略进而使患者达到最佳结局。

中文标题:

2021 ESVS临床实践指南:静脉血栓形成的管理

英文标题:

European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis

发布机构:

欧洲血管外科学会

发布日期:

2020-12-09

简要介绍:

2020年12月,欧洲血管外科学会(ESVS)发布了静脉血栓形成的管理指南,指南的主要目的是帮助临床医生选择最佳管理策略进而使患者达到最佳结局。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ESVS临床实践指南:静脉血栓形成的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=383ab1c002033146, title=2021 ESVS临床实践指南:静脉血栓形成的管理, enTitle=European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis, guiderFrom=Eur J Vasc Endovasc Surg . 2020 Dec 9;, authorId=0, author=, summary=2020年12月,欧洲血管外科学会(ESVS)发布了静脉血栓形成的管理指南,指南的主要目的是帮助临床医生选择最佳管理策略进而使患者达到最佳结局。, cover=https://img.medsci.cn/20201230/1609341943818_2020535.jpg, journalId=0, articlesId=null, associationId=638, associationName=欧洲血管外科学会, associationIntro=欧洲血管外科学会开展欧洲血管外科医生的培训(EVST),每年举行一次年会,旨在收集欧洲血管外科医生的培训和教育的信息,并将有关的血管外科研究付诸实践。, copyright=0, guiderPublishedTime=Wed Dec 09 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年12月,欧洲血管外科学会(ESVS)发布了静脉血栓形成的管理指南,指南的主要目的是帮助临床医生选择最佳管理策略进而使患者达到最佳结局。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=582, tagName=静脉血栓)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=582, guiderKeyword=静脉血栓, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13821, appHits=779, showAppHits=0, pcHits=1891, showPcHits=13042, likes=10, shares=58, comments=52, approvalStatus=1, publishedTime=Thu Dec 31 00:27:28 CST 2020, publishedTimeString=2020-12-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Dec 30 23:25:51 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 20:15:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ESVS临床实践指南:静脉血栓形成的管理.pdf)])
2021 ESVS临床实践指南:静脉血栓形成的管理.pdf
下载请点击:
评论区 (40)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214932, encodeId=1ef412149321d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Wed Apr 27 06:35:56 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194959, encodeId=92b7119495960, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/1ac509b02e474a62b04821218d545591/41999e8f8740491a9831ef637a726745.jpg, createdBy=6c8a5450541, createdName=ms8000000374682656, createdTime=Sat Feb 19 03:47:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082002, encodeId=7833108200265, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b6a1397021, createdName=xiaoping_xxp, createdTime=Mon Dec 20 09:29:37 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060172, encodeId=460010601e279, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7825460076, createdName=ms3000001870725950, createdTime=Wed Oct 13 16:58:05 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058750, encodeId=43a61058e5052, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ad2152218, createdName=朵小朵朵, createdTime=Fri Oct 08 22:46:59 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2022-04-27 su_yi_fei

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214932, encodeId=1ef412149321d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Wed Apr 27 06:35:56 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194959, encodeId=92b7119495960, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/1ac509b02e474a62b04821218d545591/41999e8f8740491a9831ef637a726745.jpg, createdBy=6c8a5450541, createdName=ms8000000374682656, createdTime=Sat Feb 19 03:47:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082002, encodeId=7833108200265, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b6a1397021, createdName=xiaoping_xxp, createdTime=Mon Dec 20 09:29:37 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060172, encodeId=460010601e279, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7825460076, createdName=ms3000001870725950, createdTime=Wed Oct 13 16:58:05 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058750, encodeId=43a61058e5052, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ad2152218, createdName=朵小朵朵, createdTime=Fri Oct 08 22:46:59 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2022-02-19 ms8000000374682656

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214932, encodeId=1ef412149321d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Wed Apr 27 06:35:56 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194959, encodeId=92b7119495960, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/1ac509b02e474a62b04821218d545591/41999e8f8740491a9831ef637a726745.jpg, createdBy=6c8a5450541, createdName=ms8000000374682656, createdTime=Sat Feb 19 03:47:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082002, encodeId=7833108200265, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b6a1397021, createdName=xiaoping_xxp, createdTime=Mon Dec 20 09:29:37 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060172, encodeId=460010601e279, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7825460076, createdName=ms3000001870725950, createdTime=Wed Oct 13 16:58:05 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058750, encodeId=43a61058e5052, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ad2152218, createdName=朵小朵朵, createdTime=Fri Oct 08 22:46:59 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2021-12-20 xiaoping_xxp

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214932, encodeId=1ef412149321d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Wed Apr 27 06:35:56 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194959, encodeId=92b7119495960, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/1ac509b02e474a62b04821218d545591/41999e8f8740491a9831ef637a726745.jpg, createdBy=6c8a5450541, createdName=ms8000000374682656, createdTime=Sat Feb 19 03:47:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082002, encodeId=7833108200265, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b6a1397021, createdName=xiaoping_xxp, createdTime=Mon Dec 20 09:29:37 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060172, encodeId=460010601e279, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7825460076, createdName=ms3000001870725950, createdTime=Wed Oct 13 16:58:05 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058750, encodeId=43a61058e5052, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ad2152218, createdName=朵小朵朵, createdTime=Fri Oct 08 22:46:59 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2021-10-13 ms3000001870725950

    很棒

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214932, encodeId=1ef412149321d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Wed Apr 27 06:35:56 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194959, encodeId=92b7119495960, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/1ac509b02e474a62b04821218d545591/41999e8f8740491a9831ef637a726745.jpg, createdBy=6c8a5450541, createdName=ms8000000374682656, createdTime=Sat Feb 19 03:47:42 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082002, encodeId=7833108200265, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b6a1397021, createdName=xiaoping_xxp, createdTime=Mon Dec 20 09:29:37 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060172, encodeId=460010601e279, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7825460076, createdName=ms3000001870725950, createdTime=Wed Oct 13 16:58:05 CST 2021, time=2021-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058750, encodeId=43a61058e5052, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ad2152218, createdName=朵小朵朵, createdTime=Fri Oct 08 22:46:59 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2021-10-08 朵小朵朵

    很棒

    0

拓展阅读

2014 ASCO 癌症患者静脉血栓栓塞防治指南(更新版)

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2015-01-20

2015 ACFAS临床共识声明:需要进行固定的足踝部手术以及外伤静脉血栓血栓栓塞疾病的危险因素,预防和诊断

美国足踝外科医师协会(ACFAS,American College of Foot and Ankle Surgeons) · 2015-03-19

NCS:2015 预防神经重症监护患者静脉血栓指南

美国神经重症监护学会(NCS,Neurocritical Care Society) · 2015-05-14

2015 BCSH指南:肿瘤相关静脉血栓形成

英国血液学标准委员会(BCSH,British Committee for Standards in Haematology) · 2015-06-26

2016 妊娠相关静脉血栓栓塞症的诊断共识

国外妇产科相关专家组 · 2016-08-10